Which hedge funds own FENC? FENNEC PHARMACEUTICALS INC, Q2 2026 13F holders
Follow
19 tracked hedge funds disclosed a position in FENC (FENNEC PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $52.2m in total. The largest holder by portfolio weight is Solas Capital Management, LLC at 10.9% of its book. 8 opened a new position this quarter: Prospect Capital Advisors, LLC, CenterBook Partners LP, Brevan Howard Capital Management LP, Renaissance Technologies LLC. 1 exited: Southpoint Capital Advisors LP.
19
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
8
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
1
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$11.3m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$16.9m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$52.2m
Combined value
Sum of the holders' reported positions in the security.
1.5%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.